Leah Fletcher named HPSU Founder of the Year for cannabinoid meds
Fletcher is interested in how cannabinoids can be regulated and used in pharmaceutical contexts, she told SiliconRepublic.com. Read more: Leah Fletcher named HPSU Founder of the Year for cannabinoid meds
Leah Fletcher, the founder and CEO of Dunbar Pharma, Ireland's first EU GMP-certified cannabinoid pharmaceutical manufacturer, has been named the Enterprise Ireland High Potential Start-Up (HPSU) Founder of the Year. Fletcher's company, based in Athlone, produces WaterClear THC, a trademarked plant-derived dronabinol active pharmaceutical ingredient.
Fletcher's interest in cannabinoid medicines began while living in Canada during the time cannabis was legalised there, and she has since focused on moving cannabinoids from uncertainty into a pharmaceutical framework, emphasizing evidence, quality, consistency, compliance, and patient safety. The Founder of the Year Award recognizes leading entrepreneurs emerging from Enterprise Ireland's cohort of supported founders and businesses, with this year's finalists including Lia Eyecare's Breda O’Regan, Mark Birrane of Wondr, Robert Norton of Kaptea, and Seán Kirwan of MedWrite AI.
Brief written by urgent.news from Silicon Republic's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
